Carboplatin and paclitaxel adjuvant chemotherapy in primitive neuroectodermal tumor of the uterine corpus.
Primitive neuroectodermal tumor of the uterine corpus (PNET) is rare and appears to have an aggressive clinical course. We report on a postmenopausal woman with optimal surgically cytoreduced advanced-stage PNET in which adjuvant combination chemotherapy with platinum and taxane agents was unsuccessful in extending her disease-free survival.
Shah
Jay P
JP
Division of Gynecology Oncology, Wayne State University and Karmanos Cancer Center, Detroit, MI 48201, USA. jpshah@med.wayne.edu
Jelsema
Jodilyn
J
Bryant
Christopher S
CS
Ali-Fehmi
Rouba
R
Malone
John M
JM
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D016190:Carboplatin / Q000008:administration & dosage; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D018242:Neuroectodermal Tumors, Primitive / Q000150:complications / Q000188:drug therapy* / Q000628:therapy; D017239:Paclitaxel / Q000008:administration & dosage; D017698:Postmenopause; D018714:Radiotherapy, Adjuvant; D014592:Uterine Hemorrhage / Q000209:etiology; D014594:Uterine Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000628:therapy
D016190:Carboplatin; D017239:Paclitaxel